Related references
Note: Only part of the references are listed.CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
Letizia Porcelli et al.
CANCERS (2019)
Cancer-Associated Fibroblasts' Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
Mohammad Awaji et al.
CANCERS (2019)
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs
Barbara De Filippis et al.
MEDICINAL CHEMISTRY RESEARCH (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines
Alessandra Ammazzalorso et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
Antonella Argentiero et al.
CANCERS (2019)
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
Andrea Emanuele Guerini et al.
CANCERS (2019)
Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells
Qing-Ling Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Invasive Colon Cancer Cells Induce Transdifferentiation of Endothelium to Cancer-Associated Fibroblasts through Microtubules Enriched in Tubulin-β3
Marta Ewelina Wawro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Repurposed Drugs in Pancreatic Ductal Adenocarcinoma An Update
Matthias Ilmer et al.
CANCER JOURNAL (2019)
Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia
Licai He et al.
EXPERIMENTAL CELL RESEARCH (2018)
Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients
Gustav Arvidsson et al.
HAEMATOLOGICA (2018)
Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells
K. Canova et al.
TOXICOLOGY IN VITRO (2018)
Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients
Gustav Arvidsson et al.
HAEMATOLOGICA (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
Serena Veschi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
Nilambra Dogra et al.
SCIENTIFIC REPORTS (2018)
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells
Rosalba Florio et al.
SCIENTIFIC REPORTS (2018)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential
Yu-Chen Lo et al.
SCIENTIFIC REPORTS (2017)
Repositioning approved drugs for the treatment of problematic cancers using a screening approach
Hristo P. Varbanov et al.
PLOS ONE (2017)
Pancreatic cancer: yesterday, today and tomorrow
Daniel Ansari et al.
FUTURE ONCOLOGY (2016)
Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro
Vera Kralova et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies
Tasuku Matsuoka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker
Wei Yu et al.
ONCOTARGET (2016)
Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
Valerie B. Sampson et al.
ONCOTARGET (2016)
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C. Arend et al.
ONCOTARGET (2016)
Activation of WNT/β- Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61
Makoto Sano et al.
NEOPLASIA (2016)
Albendazole as a promising molecule for tumor control
L. S. E. P. W. Castro et al.
REDOX BIOLOGY (2016)
Potential Anti-cancer Drugs Commonly Used for Other Indications
Veronika Hanusova et al.
CURRENT CANCER DRUG TARGETS (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Zhi-Jie Hou et al.
ONCOTARGET (2015)
Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
Andrew R. Larsen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Cholecystokinin and pancreatic cancer: the chicken or the egg?
Jill P. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
Microtubules in Cell Migration
Sandrine Etienne-Manneville
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 29 (2013)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
Paul A. Spagnuolo et al.
BLOOD (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint
Daniela A. Brito et al.
CURRENT BIOLOGY (2006)
CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line
YT Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cell death by mitotic catastrophe: a molecular definition
M Castedo et al.
ONCOGENE (2004)
Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy
C Vogel et al.
ONCOGENE (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Share Paper
